paroxetine has been researched along with Hypothermia in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (45.45) | 18.2507 |
2000's | 6 (54.55) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bosch, A; Del Castillo, JC; Del Río, J; Heras, B; Lasheras, B; Martínez-Esparza, J; Monge, A; Mourelle, M; Oficialdegui, AM; Orús, L; Palop, JA; Pérez-Silanes, S; Roca, J; Tordera, R | 1 |
Bull, EJ; Fone, KC; Hutson, PH | 1 |
Camarasa, J; Escubedo, E; Farré, A; Fisas, MA | 1 |
Al Chekakie, MO; Ketz, JM; Whinney, CM | 1 |
Cowen, PJ; Odontiadis, J; Pearson, G; Sargent, P; Williamson, DJ | 1 |
Cryan, JF; Leonard, BE; McGrath, C; Norman, TR | 2 |
Baker, GB; Bourin, M; Colombel, MC; Redrobe, JP | 1 |
Aguirre, N; Barrionuevo, M; Del Río, J; Lasheras, B; Ramírez, MJ | 1 |
Aguirre, N; Hervías, I; Lasheras, B | 1 |
Middlemiss, DN; Price, GW; Roberts, C; Watson, J | 1 |
1 review(s) available for paroxetine and Hypothermia
Article | Year |
---|---|
SB-236057-A: a selective 5-HT1B receptor inverse agonist.
Topics: Animals; Autoreceptors; Brain; Cyclic AMP; Humans; Hypothermia; Indoles; Microdialysis; Paroxetine; Pyridines; Radioligand Assay; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 2001 |
1 trial(s) available for paroxetine and Hypothermia
Article | Year |
---|---|
Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Platelets; Double-Blind Method; Humans; Hydrocortisone; Hypothermia; Male; Middle Aged; Paroxetine; Piperazines; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Triazoles | 1997 |
9 other study(ies) available for paroxetine and Hypothermia
Article | Year |
---|---|
New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Carrier Proteins; Colony-Forming Units Assay; Conditioning, Operant; Cyclic AMP; HeLa Cells; Humans; Hypothermia; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Nerve Tissue Proteins; Piperazines; Radioligand Assay; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Thiophenes | 2001 |
Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity.
Topics: Animals; Brain; Corticosterone; Exploratory Behavior; Hydroxyindoleacetic Acid; Hypothermia; In Vitro Techniques; Male; Maze Learning; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Piperazines; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Social Behavior; Substance Withdrawal Syndrome | 2003 |
Effects of lesopitron on the central nervous system arising from its interaction with 5-HT1A receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Catalepsy; Central Nervous System; Central Nervous System Depressants; Drug Interactions; Female; Hippocampus; Hypothermia; In Vitro Techniques; Ligands; Male; Mice; Paroxetine; Piperazines; Pyrimidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Serotonin Syndrome; Species Specificity | 2004 |
Hypothermia in a patient receiving risperidone and paroxetine.
Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dementia; Female; Humans; Hypothermia; Paroxetine; Risperidone | 2006 |
Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected?
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Drug Therapy, Combination; Exploratory Behavior; Hypothermia; Male; Olfactory Bulb; Paroxetine; Pindolol; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists | 1998 |
Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amines; Animals; Antidepressive Agents; Apomorphine; Brain; Clonidine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Hypothermia; Indoles; Male; Mice; Motor Activity; Norepinephrine; Paroxetine; Pindolol; Piperazines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming | 1998 |
Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents, Second-Generation; Depression; Disease Models, Animal; Drug Synergism; Exploratory Behavior; Hypothermia; Male; Motor Activity; Olfactory Bulb; Paroxetine; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists | 1999 |
Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity.
Topics: Animals; Antioxidants; Astrocytes; Binding Sites; Carrier Proteins; Fever; Frontal Lobe; Glial Fibrillary Acidic Protein; Hippocampus; Hypothermia; Male; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Nerve Tissue Proteins; Neuroprotective Agents; Paroxetine; Pyramidal Cells; Rats; Rats, Wistar; Serotonin; Serotonin Plasma Membrane Transport Proteins; Thioctic Acid | 1999 |
2-Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Animals; Body Temperature; Brain; Carrier Proteins; Corpus Striatum; Dopamine; Drug Synergism; Frontal Lobe; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypothermia; Male; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurotoxins; Niacinamide; Organ Specificity; Paroxetine; Rats; Rats, Wistar; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2000 |